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        B cells responding to antigen in a T cell  –  depen-
dent response can be activated to become short-
lived plasma cells with no memory capabilities, 
or germinal center cells, which mature to be-
come either long-lived plasma cells or memory 
B cells. The nature of the antibody-producing 
cell infl  uences the duration of the antibody re-
sponse as well as the affi   nity and isotype of the 
antibody that is made, all of which constitute im-
portant parameters of protective immunity. The 
phenotype of the autoreactive B cell producing 
the autoantibody in patients with autoimmune 
disease may also infl  uence both the pathogenic-
ity of the autoantibody and the response to ther-
apy. Antibody responses that include a memory 
cell compartment may be important in pro-
tective immunity, but as autoantibody responses 
they may be more diffi   cult to eradicate. Thus, 
understanding the conditions that lead to the 
generation of either short-lived plasma cells or 
long-lived plasma cells and memory cells may be 
of considerable clinical importance. 
  We have previously described a model of 
antigen-induced autoimmunity in which we can 
examine the inductive phase of the autoreactive 
humoral response. BALB/c mice immunized 
with a peptide mimotope of double-stranded 
DNA (dsDNA) will develop antibodies that are 
cross-reactive with dsDNA and peptide. These 
antibodies deposit in renal glomeruli and cause 
proteinuria. Because there is minimal cellular 
infi  ltrate in the kidney, probably because of a 
lack of renal vulnerability to antibody-mediated 
disease in this strain, the model is one of ne-
phrotic syndrome (  1  ). The autoantibody response 
in these mice is T cell  –  dependent, with antigen-
specifi  c T cells producing Th1 cytokines on 
antigen challenge (  2  ). 
  Our understanding of the immunological 
function of       chain  –  associated FcRs has been 
facilitated by studies from Takai et al. (  3  ) on 
FcR-associated       chain  –  null mice (Fc            /      ). 
The Fc            /       mice have a selective defect in the 
expression of FcRs on the cell surface as well as 
in the FcR-mediated signal cascade. Interest-
ingly, disruption of the FcR       chain in NZB/
CORRESPONDENCE  
  Betty Diamond:  
 bdiamond@nshs.edu
  Abbreviations used: AID, acti-
vation-induced cytidine deami-
nase; BMDC, BM-derived DC; 
dsDNA, double-stranded DNA; 
MAP, multiple antigenic 
peptide. 
  S.J. Kim and M. Caton contributed equally to this paper. 
      The online version of this article contains supplemental material.     
  Increased IL-12 inhibits B cells  ’   
diff  erentiation to germinal center cells 
and promotes diff  erentiation to short-lived 
plasmablasts 
    Sun Jung     Kim  ,    1       Michele     Caton  ,    2       Chuansheng     Wang  ,    1       Magi     Khalil  ,    1     
  Zhi-Jie     Zhou  ,    1       John     Hardin  ,    1     and   Betty     Diamond      1,2     
  1  Autoimmune Disease Laboratory, Feinstein Institute for Medical Research, Manhasset, NY 11030 
  2  Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461     
  B cells activated by antigen in T cell  –  dependent immune responses can become short-lived 
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cells, which show evidence of affi  nity maturation and, in the case of plasma cells, migrate 
to the bone marrow. We show that this cell fate decision can be governed by the cytokine 
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receptor      chain exhibited an activated phenotype in vitro. They secreted more of the 
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splenic plasma cells, with ensuing low affi  nity antibodies and a diminished recall response. 
Understanding the factors that regulate antigen-activated B cell differentiation and mem-
ory cell formation has implications for both antibody-mediated autoimmune disease and 
protective antibody responses. 
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signifi  cantly more glomerular IgG deposition than WT kid-
neys, and the mice displayed increased proteinuria (  Fig. 1 c  ). 
Thus, the antibodies from Fc            /       mice, although of lower 
affi   nity than the antibodies in WT mice, were still of suffi   cient 
affi   nity to cause glomerular dysfunction. This observation is 
NZW mice uncouples immune complex formation from the 
infl  ammatory response in the kidney, implying a pathogenic 
role of FcR       chain in autoimmune disease (  4  ). 
  There are several factors involved in determining the 
phenotype of antigen-experienced B cells, including BCR sig-
nal strength (  5  ), expression of transcription factors (  6  ), and 
costimulatory infl  uences (  7  –  9  ). In the course of studying re-
nal pathology in peptide-immunized mice defi  cient in the 
FcR       chain (Fc            /      ), we made the surprising observation 
that Fc            /       mice preferentially develop short-lived plasma 
cells and fail to develop a germinal center response. We show 
that this altered B cell response is a consequence of increased 
IL-12 production by DCs. 
    RESULTS   
  Fc          /      mice display a distinct humoral response to antigen 
  Immunization of BALB/c mice with a peptide mimotope 
of dsDNA, DWEYSVWLSN, octamerized on a polylysine 
backbone (multiple antigenic peptide [MAP] peptide) induces 
antibodies that cross-react with peptide and dsDNA (  1  ). We 
immunized Fc            /       and WT mice i.p. with MAP peptide in 
CFA and boosted with antigen in IFA on days 7 and 14. By day 
28, Fc            /       mice generated signifi  cantly higher serum titers 
of both antipeptide (approximately fi  vefold) and anti-dsDNA 
antibody (approximately sevenfold;   Fig. 1 a  ).   The diff  erence 
in serum antibody reactivity did not refl  ect a diff  erence in 
the kinetics of the response, as both strains exhibited a similar 
timing of antibody production (  Fig. 1 a  ). An antigen-specifi  c 
IgM response was induced in WT and Fc            /       mice. Consis-
tent with the IgG response, there was a higher IgM response 
in Fc            /       mice at week 2, but this declined to the basal level 
by week 4 in both strains (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20070731/DC1). 
  One explanation for the greater IgG serum reactivity in 
Fc            /       mice would be an increased affi   nity of antipeptide anti-
bodies. We, therefore, performed inhibition ELISAs with sol-
uble peptide and calculated apparent affi   nities by determining 
the molar concentration of soluble antigen that led to 50% 
inhibition of the antibody reactivity (  10  ). Contrary to our initial 
expectation, antipeptide antibodies from Fc            /       mice had a 
log lower apparent affi   nity than antipeptide antibodies from 
WT mice (1.4   ×   10  5   vs. 2.2   ×   10  6  ; P   ≤   0.01), demonstrating 
that the increased titers resulted from the production of more 
antigen-specifi  c antibody. 
  Furthermore, although IgG1 was the predominant iso-
type observed in both the antipeptide and anti-dsDNA re-
sponse in WT mice, Fc            /       mice produced both IgG1 and 
IgG2a antipeptide (  Fig. 1 b  ) and anti-dsDNA antibodies (not 
depicted). This did not refl  ect an intrinsic bias toward in-
creased IgG2a, as the isotype distribution for total serum IgG 
was similar in both mouse strains (not depicted). 
  Because the diff  erence in antibody titer between strains 
was     5  –  10-fold, we believed it was important to ask whether 
this increase in serum antibody titer might be of pathological 
signifi  cance. Kidneys from MAP peptide  –  immunized Fc            /       
mice, analyzed 13 wk after the initial antigen challenge, had 
    Figure 1.         Fc          /      mice display an increased production of antigen-
specifi  c antibodies in their serum and increased renal antibody de-
position.   (a)  Fc        /      (gray triangles) and WT (black squares) mice (  n   = 5 in 
each group) were immunized with 100   μ  g MAP peptide and boosted twice 
(arrows indicate time of boosts). Serum was collected on days 0, 14, 28, 
42, and 56, and antipeptide and anti-dsDNA IgG ELISAs were performed. 
P   ≤   0.05 in both graphs. (b) Mice were immunized as described in a. 7-wk 
serum was assayed for isotype-specifi  c antipeptide antibody ELISAs. Titra-
tions were twofold and began at the dilution indicated on the x-axis. Gray 
triangles show Fc         /      mice and black squares show WT mice. IgG1, P = 
0.02; IgG2a, P = 0.048.   n   = 5. (c) Kidneys were taken at day 91, and sec-
tions were stained for IgG deposition. Sections shown above are repre-
sentative of fi  ve mice in each group. Sections were magnifi  ed 100  ×  . Bars, 
50   μ  m. 50 glomeruli were counted in each kidney section, and the percent 
positive for IgG deposition was graphed. *, P   ≤   0.05. Proteinuria was de-
termined by measuring the amount of protein in the urine of mice at day 
91 after immunization. (d) Both WT and Fc         /      mice were immunized 
with 100   μ  g MAP peptide in CFA on day 0 and boosted on day 7 with 
MAP peptide in IFA. On day 56, mice were challenged with 100   μ  g MAP 
peptide in IFA, and serum was collected 5 d after challenge. Antipeptide 
ELISAs were performed. P   ≤   0.05. (e) WT and Fc         /      mice  (fi  ve in each 
group) were immunized with 100   μ  g 10  –  2  –  BSA and boosted twice. Day-0, 
-14, -28, and -42 serum was assayed by ELISA for anti  –  10-2 IgG. P   ≤   0.05. 
Data are presented as mean   ±   SD.     JEM VOL. 205, September 29, 2008 
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  Differential humoral response in Fc          /      mice is not 
determined by B cells 
  The increased antipeptide and anti-DNA response in Fc            /       
mice might refl  ect either a B cell  –  intrinsic phenotype or, 
alternatively, a diff  erent response to immunization in non-B 
cells. To test whether the diff  erence was B cell intrinsic, splenic 
B cells from WT or Fc            /       mice were transferred to B cell  –
  defi  cient BALB/c mice (muMT). Both WT B cell  –  reconsti-
tuted and Fc            /       B cell  –  reconstituted muMT mice were 
immunized with MAP peptide. As shown in   Fig. 2  , there was 
no statistically signifi  cant diff  erence in serum antipeptide re-
sponse between WT and Fc            /       B cell  –  reconstituted mice.   
Moreover, analysis of splenic B cell subsets (mature vs. im-
mature and transitional vs. follicular vs. marginal zone) con-
fi  rmed that there was no diff  erence in B cell diff  erentiation 
between Fc            /       and WT BALB/c B cells. The expression of 
several cell surface markers (CD22, CD40, CD43, CD79b, 
CD27, MHC II, Fas, CD80, and CD86) also was not diff  er-
ent between Fc            /       and WT BALB/c B cells. B cell function, 
assayed by IgM-mediated apoptosis and B cell proliferation to 
anti-IgM plus anti-CD40 antibody or anti-CD40 antibody 
plus IL-4, was also similar between both strains (unpublished 
data). Thus, the phenotype and function of naive B cells of 
both strains were indistinguishable. 
  Fc          /      B cells preferentially differentiate into short-lived 
plasma cells 
  Because the antibody response in Fc            /       mice was of low af-
fi  nity and the memory response was impaired, we hypothesized 
that there was a defect in germinal center maturation, which 
generates both memory B cells and long-lived plasma cells, 
and a preferential generation of short-lived plasma cells (  13  –  16  ). 
Short-lived plasma cells develop in T cell  –  dependent responses 
but do not display affi   nity maturation and are not associated 
with a clonally related memory B cell population (  17, 18  ). 
After activation with antigen, short-lived plasma cells reside 
primarily in the extrafollicular foci of the spleen, whereas 
long-lived plasma cells preferentially migrate to the BM (  16  –  19  ). 
First, we determined the number of antibody-secreting 
cells (including plasmablasts, short-lived plasma cells, and 
long-lived plasma cells) in the spleen. There was a higher 
percentage of B220  lo   and CD138  +   cells in the B cell popula-
tion in MAP peptide  –  immunized Fc            /       mice compared 
with WT mice on day 8 (  Fig. 3 a  ).   To determine the location 
of B220  lo   and CD138  +   cells within the spleen, immunohisto-
chemistry was performed on spleens of immunized mice. 
The majority of CD138  +   cells were positioned outside the B 
cell follicles where short-lived plasma cells reside (  Fig. 3 b  ). 
CD138  +   cells colocalized with kappa chain positivity but not 
with CD4 positivity (unpublished data). To confi  rm this ob-
servation, we also performed peptide-specifi  c ELISPOT as-
says of splenic B cells.   Fig. 3 c   shows that 2.5-fold more cells 
secreting specifi  c antibody were present in spleens of Fc            /       
mice than in WT spleens. By day 28, splenic plasma cells 
from both Fc            /       and WT mice declined in number, pre-
sumably because of apoptosis of short-lived plasma cells. 
consistent with clinical experience where a four- to eightfold 
increase in autoantibody titer may correlate with the onset of 
disease or with increased disease activity. For example, an an-
tinuclear antibody titer of 1:40 is normal, whereas an eight-
fold increase to 1:320 is highly signifi  cant for disease. Likewise, 
a four to eightfold increase in anti-DNA antibody titer in a 
patient with SLE will often precede a clinical fl  are (  11  ). 
  High affi   nity antibody responses are generated by a ger-
minal center reaction in which B cells undergo somatic hy-
permutation and there is selection for survival of B cells 
making the highest affi   nity antibodies. These cells mature to 
become long-lived plasma cells and memory cells. To deter-
mine if the lack of a high affi   nity antibody response refl  ected 
a failure of B cells to undergo germinal center maturation, we 
questioned whether Fc            /       mice developed a memory re-
sponse. WT and Fc            /       mice were immunized and boosted 
with MAP peptide. 8 wk later, mice were challenged with 
100   μ  g MAP peptide. 5 d later, blood was collected to mea-
sure the antipeptide response in serum.   Fig. 1 d   shows that 
WT mice have a rapid increase in the serum antipeptide re-
sponse, which was not observed in Fc            /       mice. These data 
suggest a signifi  cant reduction in the population of memory 
B cells in Fc            /       mice. 
  To determine whether Fc            /       mice immunized with a 
nonself antigen would also develop an enhanced serum re-
sponse, we examined the response of Fc            /       mice to 10  –  2, a 
peptide mimotope of phosphorylcholine, conjugated to BSA 
(  12  ). As seen in   Fig. 1 e  , Fc            /       mice made signifi  cantly more 
anti  –  10-2 antibodies (an approximately threefold increase in 
titer) than WT mice. In addition, although WT mice made 
predominantly IgG1 anti  –  10-2 antibodies, Fc            /       mice also 
produced antigen-specifi  c IgG2a antibodies (unpublished data). 
Thus, the strain-specifi  c diff  erence in antibody response was 
not limited to an autoreactive response. 
    Figure 2.         Antipeptide response of muMT mice reconstituted with 
either WT B cells or Fc          /      B cells.   Spleens were taken from 6  –  8-wk-
old WT and Fc         /      mice. B cells were purifi  ed as described in Materials and 
methods, and 2   ×   10  7   total B cells were adoptively transferred to muMT 
mice i.v. After 2 wk, muMT mice with WT B cells or Fc         /      B cells were 
immunized with 100   μ  g MAP peptide as described. Blood was collected on 
days 0, 14, 28, and 42, and the antipeptide antibody was measured by 
ELISA. Closed circles, muMT mice with WT B cells; open circles, muMT 
mice with Fc         /      B cells. Each circle represents an individual mouse, and 
the horizontal bar is the mean.     2440 DENDRITIC CELLS INFLUENCE B CELL FATE   | Kim et al. 
These results were consistent with the preferential generation 
of short-lived plasma cells in Fc            /       mice in contrast to the 
predominance of long-lived plasma cells present in the BM of 
WT mice. 
  Because the antipeptide antibody response was previously 
shown to be a T cell  –  dependent response in WT mice (  2  ), 
we questioned whether the antibody response in Fc            /       mice 
was also T cell dependent, as it displayed less evidence of ger-
minal center formation.   Fig. 4 a   shows that antibody gener-
ation is abolished in CD4 T cell  –  depleted mice.   Thus, the 
diminished germinal center response is not caused by an ab-
sent T cell response. 
  Antigen-specifi  c T cells are activated by MAP peptide 
immunization in Fc            /       mice. To demonstrate T cell activa-
tion in Fc            /       mice, we assessed antigen-specifi  c prolifera-
tion of T cells from MAP peptide  –  immunized mice. T cells 
from MAP peptide  –  immunized Fc            /       and WT mice prolif-
erated in response to antigen (  Fig. 4 b  ). In fact, the response 
of T cells from Fc            /       T cells was greater than that of WT T 
cells. To ascertain whether this enhanced T cell response re-
fl  ected a change in T cell repertoire, we assessed V      usage. 
  Fig. 4 c   shows that there was no signifi  cant diff  erence in 
TCR V      chain usage between WT and Fc            /       mice, either 
before or after MAP peptide immunization. Furthermore, 
antigen-specifi  c T cells from both strains produced IL-2 and 
IFN-      (unpublished data). These data demonstrate that T 
cells in Fc            /       mice were activated to at least the same extent 
as T cells from WT mice after MAP peptide immunization. 
Thus, the altered antibody response is not a consequence of a 
failure of T cell priming. 
  Fc          /      mice display a diminished germinal center response 
  To demonstrate directly that Fc            /       mice display reduced 
germinal center maturation of B cells, we asked whether the 
reduced affi   nity of serum antibodies in Fc            /       mice refl  ected 
a relative lack of somatic hypermutation occurring in the 
Fc            /       mice, as somatic hypermutation is a feature of the 
germinal center response and a critical contribution to affi   nity 
maturation. To address this question, we generated antigen-
specifi  c hybridomas from WT and Fc            /       mice immunized 
with MAP peptide. We examined the number of mutations 
in the region downstream of the rearranged J  H   in B cells 
making antipeptide antibody. We chose to enumerate muta-
tions in this region because it has been shown to undergo 
hypermutation. Because it is not a coding region, it is not 
subject to the pressures of selection. As seen in   Fig. 5 a  , 
hybridomas from Fc            /       mice had many fewer mutations.   
Splenic histology displayed fewer germinal centers in Fc            /       
mice after immunization (  Fig. 5 b  ). This was confi  rmed 
by quantifi  cation of B220  +   PNA  +   cells in the spleen (Table 
S1, available at http://www.jem.org/cgi/content/full/jem
.20070731/DC1). There were very few PNA  +   cells in the 
B220  +   population in Fc            /       mice on days 8 and 16 after im-
munization compared with WT mice (  Fig. 5 c  ). We also 
measured activation-induced cytidine deaminase (AID) in-
duction in germinal center B lymphocytes because expression 
  Long-lived plasma cells migrate to the BM, where they 
secrete antibody. To determine whether long-lived plasma cells 
were being generated in Fc            /       mice, we enumerated plasma 
cells by peptide-specifi  c ELISPOT assays in the BM. Plasma 
cells were detectable in the BM between days 21 and 35 after 
the initial immunization. Fc            /       mice had 5.3-fold fewer 
peptide-specifi  c plasma cells in the BM on day 35 (  Fig. 3 d  ). 
    Figure 3.         Immunized Fc          /      mice have increased numbers of 
plasma cells in their spleen and decreased numbers in their BM 
compared with WT mice.   (a) Spleens were taken from WT and Fc         /     
mice on days 0, 8, and 12 after immunization, and splenocytes were 
stained with PE-conjugated goat anti  –  mouse CD138 and FITC-conjugated 
goat anti  –  mouse B220. The percentage of cells that were CD138  +   and 
B220  lo   was analyzed by FlowJo software. Mean   ±   SD of two independent 
experiments is shown, and each experiment contained pooled cells from 
three mice. (b) Spleens were taken at days 0, 4, and 8 after immunization, 
and frozen tissue sections were incubated with anti  –  B220-FITC (green) 
and anti  –  CD138-PE (red). Results are representative of at least three mice 
per group. Images are magnifi  ed 10  ×   and insets are 40  ×  . Arrows indicate 
the position of CD138  + B220 lo   cells. Bars, 100      m. (c) Antipeptide ELISPOTs 
were performed on splenocytes taken on day 21 after immunization. 
Fc         /      mice are shown in gray and WT mice are shown in black. There 
were fi  ve mice in each group. P   ≤   0.05. Data are mean   ±   SD. (d) BM was 
obtained on days 21 and 35 after primary immunization. CD138  +   cells 
were purifi  ed by sorting. An equal number of CD138  +   cells from each 
strain were plated for an antipeptide ELISPOT assay. The number of spots 
was counted and total number of antipeptide antibody secreting cells was 
enumerated (mean   ±   SD of four mice). *, P   ≤   0.05.     JEM VOL. 205, September 29, 2008 
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of AID is suppressed in mature B cells and only expressed in 
germinal center B cells (  20  ). WT mice display a signifi  cant 
induction of AID in germinal center B cells. Fc            /       mice, 
however, did not show any signifi  cant induction of AID, 
which is consistent with a diminished germinal center reac-
tion in these mice (  Fig. 5 d  ). These studies all support a re-
duced germinal center response in Fc            /       mice. 
  Fc          /      DCs have increased IL-12 production 
and an increased ability to cause B cell proliferation 
in an IL-12  –  dependent manner 
  Vogel et al. (  21  ) showed that IL-12 can bind directly to B 
cells and induce plasma cell formation, and Dubois et al. (  22, 23  ) 
    Figure 4.         The antipeptide response in Fc          /      is T cell dependent.  
(a) Fc         /      mice were injected i.p. with 500   μ  g GK1.5 mAb (circles) or sa-
line (squares) on days      1, 0, and +1. All mice were immunized, boosted 
with 100   μ  g MAP peptide, and boosted as described in Materials and 
methods (arrows indicate time of boost). Serum was collected on days 0, 
14, 28, and 42, and an antipeptide ELISA was performed. *, P   ≤   0.05 (  n   =  3). 
(b) 10  5   BMDCs were pulsed with MAP peptide and cultured with T cells 
from MAP peptide  –  immunized WT or Fc         /      mice in a 1:1 (BMDC/T) ratio. 
3 d later,   3  H-thymidine was added and incorporated thymidine was mea-
sured. *, P   ≤   0.05. These results are representative of three independent 
experiments. (c) V      usage was measured in WT and Fc         /      mice. T cells 
were harvested from naive and MAP peptide  –  immunized WT and Fc         /     
mice as described in Materials and methods. T cells were incubated with 
peptide in vitro for 14 d. Naive and cultured CD4  +   T cells were stained 
with fl  uorochrome-labeled anti-V      chain antibodies. CD4 T cells express-
ing particular V      chains were analyzed by FlowJo software. Data are pre-
sented as mean   ±   SD.     
    Figure 5.         Fc          /      mice display a diminished germinal center re-
sponse.   (a) The JH2 to JH4 region was sequenced in MAP peptide  –  immu-
nized mice (three mice in each group). Charts depict the mean mutation 
frequencies (frequency is defi  ned as mutations per base pair sequenced   ×   
10      3  ) for the hybridoma clones that were sequenced (center of pie) and 
the proportion of sequences with mutations (numbers of mutations out-
side the pie slice). (b) Representative images of spleen sections from im-
munized WT and Fc         /      mice. Spleens were obtained on each designated 
day after immunization protocol and frozen for staining. Sections were 
stained with B cell  –  specifi  c antibody B220-PE (red) and with germinal 
center marker PNA-FITC (green; three mice in each group). Bars, 100      m. 
(c) Enumeration of PNA  +   B cells. Spleens were collected from WT and 
Fc         /      mice on days 0, 8, and 16 after immunization. Splenocytes were 
stained with FITC-conjugated PNA and PE-conjugated goat anti  –  mouse 
B220. Cells were analyzed on an LSRII and the populations of B220  + PNA +  
and B220  + PNA        were calculated by FlowJo software. Closed circles, WT 
BALB/c; open circles, Fc         /      mice. Each circle represents an individual 
mouse and the horizontal bar denotes the mean. *, P   ≤   0.05. (d) AID in-
duction in germinal center B cells. Both WT and Fc         /      mice were immu-
nized at day 0 and killed at day 12. Purifi  ed B cells were further stained 
with FITC-conjugated PNA. B220  +   and  PNA +   cells were sorted as germinal 
center cells and B220  + PNA      cells were sorted as nongerminal center cells. 
Total RNA was extracted from each population and AID expression was 
measured by real-time PCR. The analysis was performed on B cells iso-
lated from each of three WT or Fc         /      mice. Mean   ±   SD.of the individual 
mice is shown. *, P   ≤   0.05.     2442 DENDRITIC CELLS INFLUENCE B CELL FATE   | Kim et al. 
have shown that DCs can induce naive B cells to proliferate in 
an IL-12  –  dependent manner. We therefore examined whether 
BM-derived DCs (BMDCs) from Fc            /       mice were more 
potent producers of IL-12 and stimulators of B cell prolifera-
tion. IL-12 was measured in immature and LPS-matured 
BMDCs by intracellular fl  ow cytometry and cytokine ELISA. 
Flow cytometry, which measured IL-12 p40, demonstrated a 
twofold increase in the number of DCs producing IL-12 in 
Fc            /       mice (  Fig. 6 a  ).   A cytokine ELISA for IL-12 p40/70 
detected IL-12 production only by LPS-stimulated BMDCs 
and confi  rmed a two- to threefold increase in production by 
Fc            /       DCs (  Fig. 6 b  ). Real-time PCR also demonstrated 
increased induction of IL-12p35 and p40 in LPS-stimulated 
BMDC from Fc            /       mice (  Fig. 6 c  ). Fc            /       BMDCs also 
displayed signifi  cantly higher expression of MHC II, CD80, 
and CD86 than WT BMDCs (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20070731/DC1). Fi-
nally, we measured IL-12 expression in splenic DCs after MAP 
peptide immunization in vivo. Both WT and Fc            /       mice 
were immunized. On days 1 and 3, total splenic DCs were 
purifi  ed and further cultured for 16 h to permit cytokine se-
cretion.   Fig. 6 d   demonstrates that splenic DCs from Fc            /       
mice expressed about twofold more IL-12 than DCs from 
WT mice by day 3. 
  Because there are other cell types that can produce IL-12 
upon activation, we measured production of IL-12 by mac-
rophages and B cells. As seen in previous studies, LPS stimu-
lation strongly induced production of IL-12 from peritoneal 
macrophages, but there was no diff  erence between WT and 
Fc            /       macrophages. B cells from WT and Fc            /       mice also 
produced equal amounts of IL-12 p40 after upon LPS and 
LPS plus anti-CD40 antibody stimulation. (  Fig. 6 e  ). 
  To confi  rm that the increased IL-12 could lead to an ex-
panded B cell population, naive WT B cells were cultured with 
anti-CD40 antibody and irradiated BMDCs from either Fc           /       
or WT mice. After 5 d in culture, B cells proliferated in the 
presence of Fc            /       BMDCs, whereas little or no BMDC-de-
pendent proliferation was seen in the presence of WT BMDCs 
(  Fig. 7 a  ).   Furthermore, when a neutralizing anti  –  IL-12 anti-
body was added at the beginning of the culture, B cell prolifer-
ation driven by Fc            /       BMDCs decreased by as much as 80% 
(  Fig. 7 b  ). Because anti  –  IL-12 antibody recognizes both the 
p35 and the p40 subunits of IL-12 and p40 is also a subunit of 
IL-23, there is a possibility of inhibition of both cytokines 
by the anti  –  IL-12 antibody. To address this problem, IL-12a 
(p35)  –  specifi  c siRNA was used. Transfection effi   ciency was 
determined and specifi  city of IL-12a siRNA was confi  rmed 
using control siRNA and analyzing gene expression of IL-12b 
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20070731/DC1). Consistent with the results using anti  –
  IL-12 antibody, IL-12a siRNA transfection of BMDCs abro-
gated the proliferation of B cells (  Fig. 7 c  ). The inhibition was 
specifi  c, as transfection with control siRNA showed no signifi  -
cant reduction in B cell proliferation. Therefore, Fc            /       DCs 
are potent stimulators of B cell proliferation, and their stimula-
tory function depends largely on the production of IL-12. 
    Figure 6.         Fc          /      BMDCs exhibit increased IL-12 secretion com-
pared with WT BMDCs.   (a) Unstimulated and LPS-stimulated BMDCs 
were stained with anti-CD11c PE extracellularly and anti  –  IL-12-APC in-
tracellularly and analyzed by fl  ow cytometry. These results are represen-
tative of three independent experiments. (b) LPS-stimulated BMDCs were 
cultured for 24 h, and an anti  –  IL-12 cytokine ELISA was performed on 
the supernatant. Fc         /      BMDCs are shown in gray and WT BMDCs are 
shown in black. IL-12 levels were not detectable by ELISA in unstimulated 
cultures. The assay was performed in triplicate. *, P   ≤   0.05 . Results are 
representative of mean   ±   SD of three independent experiments. (c) Total 
RNA was purifi  ed from unstimulated or LPS-stimulated BMDCs for 4 h. 
1   μ  g of total RNA was used for PCR. S18 rRNA gene was amplifi  ed as an 
internal control. Relative expression of IL-12a and b was calculated as 
described in Materials and methods. *, P   ≤   0.05. The results are mean   ±   SD 
of three experiments. (d) IL-12 produced by splenic DCs. Mice were im-
munized as described previously and splenic DCs were purifi  ed on days 1 
and 3 after immunization. Cells were plated at 10  6   /ml in 24-well plates 
for 16 h. IL-12 in the supernatant was analyzed by ELISA. *, P   ≤   0.05 
(mean   ±   SD of three individual mice). (e) Splenic B cells and peritoneal 
macrophages were isolated and the purity of the populations was deter-
mined as described in Materials and methods. For B cells, 10  6   cells/ml 
were plated in 24-well plates alone, with 5   μ  g/ml of LPS, or with 5   μ  g/ml 
LPS with 20   μ  g/ml of activating anti-CD40 antibodies and incubated for 
18 h. Supernatants were harvested and IL-12 p40 was measured as de-
scribed. For macrophages, 10  6   cells/ml were cultured in 24-well plates 
with or without 2   μ  g/ml LPS for 18 h. IL-12 p40 and p70 in the superna-
tant was measured by ELISA (mean   ±   SD of four individual mice).     JEM VOL. 205, September 29, 2008 
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Fc            /      .IL-12a  +/       mice. First, we examined the eff  ect of IL-12 
in WT, Fc            /       mice, or Fc            /      .IL-12a  +/       mice. The level of 
expression of IL-12 p35 assessed by real-time PCR showed 
decreases in both WT and Fc            /      .IL-12a  +/       mice compared 
with Fc            /       mice (Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20070731/DC1). MAP peptide  –  immu-
nized Fc            /      .IL-12a  +/       mice generated a low number of anti-
peptide antibody secreting cells in spleen, which is similar to 
WT mice (  Fig. 8 c  ), and a high number of plasma cells in the 
BM, which is also similar to WT mice (  Fig. 8 d  ). The en-
hanced B cell response of the Fc            /       mice can, therefore, be 
attributed, at least in part, to increased IL-12 production by 
DCs, as it is altered when IL-12 production is diminished. 
    DISCUSSION   
  Understanding mechanisms underlying the commitment to a 
particular B cell fate has clinical importance. Memory cells 
can proliferate extensively upon secondary challenge, and 
long-lived plasma cells can secrete antibody for long periods 
of time without antigen contact. Therefore, the prevalence 
of autoreactivity in the memory population may result in a 
chronic antibody-mediated disease. In contrast, short-lived 
plasma cells may generate large amounts of a pathogenic 
  IL-12 secretion infl  uences the differentiation of plasma 
cells in vivo 
  To confi  rm that the increased IL-12 production by DCs ac-
counted for the altered antibody response seen in vivo in 
Fc            /       mice, we determined if WT mice given supplemental 
IL-12 would produce more plasma cells in spleen. WT mice 
were injected i.p. with 1   μ  g of either soluble IL-12 or saline on 
days      1, 0, and +1 of the immunization schedule. Antigen 
boosts were given with no additional IL-12. 11 d after the last 
boost, WT mice treated with IL-12 had approximately three-
fold more splenic antibody-secreting cells than untreated mice, 
which is similar to the diff  erence observed in Fc            /       mice 
(  Fig. 8 a  ).   IL-12  –  treated WT mice also experienced an     35% 
decrease in BM plasma cells, which is also similar to Fc            /       
mice (  Fig. 8 b  ). Thus, exogenous IL-12 caused WT mice to 
acquire a phenotype of antigen-specifi  c B cells similar to that 
of Fc            /       mice. We confi  rmed this observation in a study of 
    Figure 7.         Lymphocyte proliferation with BMDCs.   (a)  5   ×   10 4   WT  B 
cells were cultured for 6 d in the presence of anti-CD40 mAb with varying 
numbers of irradiated BMDCs from either WT (black bars) or Fc         /      (gray 
bars) mice. B cell proliferation was determined by   3  H incorporation. The 
assay was performed in triplicate. *, P   ≤   0.05; **, P   ≤   0.01. These results are 
mean   ±   SD of three independent experiments. (b) The proliferation assay 
was performed as above with WT B cells and Fc         /      BMDCs in the pres-
ence (gray bars) or absence (black bars) of 10   μ  g of neutralizing monoclo-
nal anti  –  IL-12 antibody. The results are reported as the difference in 
proliferation between cultures in which BMDCs are present and absent. 
These results are mean   ±   SD of three independent experiments. (c) A pro-
liferation assay was performed with siRNA-transfected BMDCs. BMDCs 
were generated from WT mice and Fc         /      mice. 10   μ  M of either anti  –  IL-12a 
or control siRNA was transfected, as described in Materials and methods, 
at day 7 of culture. The next day, siRNA-transfected and -untransfected 
DCs were incubated with 1   μ  g/ml LPS to mature DCs. Proliferation assays 
were performed as described in Materials and methods. The results are 
mean   ±   SD of fi  ve indivual mice.     
    Figure 8.         IL-12 treatment of WT mice mimics the plasma cell 
phenotype observed in Fc          /      mice.   BALB/c WT mice were injected i.p. 
with 1   μ  g rIL-12 (black bars) or saline (gray bars) on days      1, 0, and 1 
after immunization with MAP peptide. Mice were boosted as previously 
described. (a) Splenocytes were taken on day 25 after immunization, and 
peptide-specifi  c ELISPOTs were performed.   n   = 5 mice in each group. 
(b) BM was taken on day 25 after primary immunization, and CD138  +   cells 
were sorted to perform antipeptide ELISPOT assays. The number of spots 
was counted and enumerated as in the fi  gure. *, P   ≤   0.05. WT, Fc         /    ,  or 
Fc         /    .IL-12a +/       mice were immunized with 100   μ  g MAP peptide. 
(c) Splenocytes were taken on day 25 after primary immunization. Peptide-
specifi  c ELISPOTs were performed, and spots were enumerated. Each dots 
represent individual mice. *, P   ≤   0.05. (d) BM was taken on day 25 after 
immunization. CD138  + IgM      AA4.1        plasma cells were enumerated as a 
percentage of CD138  +   cell.  *,  P   ≤   0.05.   2444 DENDRITIC CELLS INFLUENCE B CELL FATE   | Kim et al. 
plasma cells, a pattern mimicking that seen in immunized 
Fc            /       mice. Therefore, IL-12 produced by DCs seems to 
be highly infl  uential in directing B cell diff  erentiation. It is 
possible that this diff  erence in diff  erentiation pathway refl  ects 
a change in the environment in which the B cell resides rather 
than a direct eff  ect on the B cell. We do not favor this expla-
nation, as chemokine expression in the spleen is similar in both 
strains (Fig. S6, available at http://www.jem.org/cgi/content/
full/jem.20070731/DC1). Furthermore, IL-12 has been shown 
by others to act directly on B cells (  21  ). Interestingly, CR2 
(CD21/CD35) has also been reported to diminish the develop-
ment of long-lived plasma cells while leaving intact the gen-
eration of short-lived plasmablasts, germinal center, and memory 
B cells. This eff  ect is mediated through the regulation of Blimp-1 
and XBP-1, which are critical transcription factors in plasma 
cell diff  erentiation (  29  ). CR2, like FcR, appears to function 
through a B cell  –  intrinsic pathway that specifi  cally arrests the 
diff  erentiation of long-lived plasma cells. We should note, 
however, that antigen-specifi  c T cell proliferation was en-
hanced in Fc            /       mice. The enhanced number of antigen-
specifi  c T cells expressing CD40L and available to interact with 
antigen-specifi  c B cells may also contribute to the preferen-
tial generation of short-lived plasma cells. Thus, both the di-
rect action of DCs on B cells as well as the action of T cells in 
Fc            /       mice may contribute to skewing the B cell response. 
  Although the diff  erences in IL-12 production between 
the mouse strains may seem small, we have previously shown 
in studies of hormonal eff  ects on B cells that a 20% change in 
expression of CD22 can aff  ect B cell receptor signaling and 
alter negative selection (  30  ). Recently, McGaha et al. (  31  ) 
have shown that a 50% increase in Fc     RIIb expression in B 
cells can prevent disease in lupus-prone mice. Thus, it should 
not be surprising that a twofold increase in IL-12 production 
by DCs can aff  ect B cell diff  erentiation. In fact, a study of ex-
perimental myasthenia gravis in mice also demonstrated that 
exogenous IL-12 given in a similar protocol led to increased 
serum antibody (  27  ). 
  A previous study reported no alteration in humoral re-
sponse to the hapten NP in Fc            /       mice. This study was 
performed on C57BL/6 mice defi  cient in the FcR       chain 
and may reveal a strain-dependent diff  erence in FcR       chain 
function. It is also possible, however, that the force of selec-
tion for high-affi   nity antibodies in the NP model is so strong 
that diff  erences in B cell diff  erentiation were obscured. Some 
eff  ects were seen that were similar to those we report. For ex-
ample, in the reported study that Fc            /       mice had fewer 
splenic germinal centers after immunization. 
  We do not yet fully understand why the absence of the       
chain leads to the observed DC phenotype. Studies on       
chain  –  defi  cient mice have focused on alterations in expression 
and function of FcRI, FcRIII, and FcRIV (  32  ). To confi  rm 
that the serological changes were mediated through FcR en-
gagement, we have immunized FcRIII-defi  cient mice with 
MAP peptide. These mice show increased serum antipeptide 
antibodies (fi  vefold increase) and an activated phenotype 
of BMDCs. Similarly, DCs derived from BM cells under 
antibody that, as shown in this study, does not necessarily need 
to be of the highest affi   nity to cause organ damage. 
  Through the analysis of Fc            /       mice, we have demon-
strated that DCs participate in determining B cell diff  erentia-
tion in vivo. Fc            /       B cells became predominantly splenic 
plasma cells upon activation instead of forming the more het-
erogeneous population of short-lived and long-lived plasma 
cells and memory cells seen in WT mice. Current data suggest 
that the majority of splenic plasma cells are short lived, whereas 
plasma cells in the BM can be either short lived or long lived 
(  15, 18, 19, 24  ). In our study, Fc            /       mice had a transient 
surge of plasma cells in the spleen, while displaying a dimin-
ished rise in plasma cells in the BM and a reduced memory B 
cell response. In contrast, WT mice had a smaller population 
of splenic plasma cells and an increase in BM plasma cells after 
immunization and demonstrated B cell memory upon sec-
ondary challenge with antigen. Fc            /       mice produced signif-
icantly higher serum titers of specifi  c antibody than WT mice 
and displayed class switching to IgG2a as well as IgG1. The 
increase in serum antipeptide and anti-DNA response appears 
to be an FcR-dependent phenomenon because Fc     RI       /       
immunized with MAP peptide showed a similar phenotype 
(Fig. S5, available at http://www.jem.org/cgi/content/full/
jem.20070731/DC1). These features of the response may ac-
count for the increased glomerular dysfunction. Interestingly, 
antibodies from Fc            /       displayed less affi   nity maturation. 
This serologic data were confi  rmed by the demonstration of 
reduced GL-7  –  positive cells in splenic B cells of Fc            /       mice 
(unpublished data) and less somatic mutation in antigen-spe-
cifi  c hybridomas. Because some studies suggest that short-
lived and long-lived plasma cells arise from completely separate 
precursors (  25  ), we are currently studying the B cells respond-
ing to antigen in WT and Fc            /       mice to determine if the 
same clones are activated or whether the plasma cell precur-
sors diff  er between the strains. 
  DCs have previously been shown to mediate a critical 
function in B cell activation by transporting antigen from the 
periphery to T and B cells     (  26  ). The altered B cell phenotype 
we observed in Fc            /       could also be traced to the infl  uence 
of Fc            /       DCs and IL-12. Fc            /       DCs had a more mature 
phenotype and produced at least twofold more IL-12 than 
WT DCs. Several studies have established a role for IL-12 in 
B cell diff  erentiation and function. IL-12 can induce plasma 
cell formation and B cell heavy chain class switching to IgG1 
and IgG2a. The switch to IgG2 is IFN-       –  dependent, whereas 
the promotion of diff  erentiation to plasma cells and the switch 
to IgG1 does not require IFN-      (  27  ). Studies in human pri-
mary B cells have also shown that IL-12 up-regulates IL-
12R     2 expression and IFN-      production by B cells, possibly 
allowing them to function as B eff  ector cells and promote the 
activation of Th1 cells (  28  ). Notably, although IL-12 pro-
motes short-lived plasma cells, perhaps in synergy with CD40L 
(  27  ), memory B cell diff  erentiation occurs independently of 
IL-12 (  22, 23  ). In our study, when IL-12 was administered to 
WT mice, the mice responded to antigen immunization with 
the generation of more splenic plasma cells and fewer BM JEM VOL. 205, September 29, 2008 
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  Adoptive transfer of B cells to muMT mice.     6-8-wk-old WT and Fc            /       
mice were killed and total splenic B cells were purifi  ed. Recipient      MT 
mice were injected with 2   ×   10  7   cells intravenously. 2 wk after transfer, both 
WT B cell  –  reconstituted and Fc            /       B cell  –  reconstituted muMT mice were 
immunized with MAP peptide as described. The antipeptide response from 
both groups was measured every 2 wk until 6 wk after immunization. 
  ELISAs.     EIA/RIA high binding 96-well plates (Costar; Corning) were 
coated with 15   μ  g/ml of the relevant peptide. For dsDNA ELISAs, plates 
were coated with 100   μ  g/ml of sonicated calf thymus DNA (Sigma-Aldrich) 
that was fi  ltered through a 0.45-  μ  m of nitrocellulose Millex-HA syringe fi  l-
ter (Millipore) to produce dsDNA. Plates were then blocked with 3% FCS 
or 5% milk. Alkaline phosphatase  –  conjugated anti  –  mouse total IgG or anti  –
  mouse isotype-specifi  c antibodies (SouthernBiotech) were used as secondary 
antibodies, and plates were developed with   p  -nitrophenyl phosphate (Sigma-
Aldrich). OD was monitored at 405 nm. 
  ELISAs determining the apparent affi   nity of peptide-specifi  c antibodies 
were performed with the following modifi  cation: sera were preincubated 
with varying concentrations of the relevant peptide before being loaded onto 
the antigen-coated plates. The K  a   was calculated as the reciprocal of the mo-
lar concentration of peptide inhibiting 50% of the binding (  10  ). 
  Memory response.     WT and Fc            /       mice were immunized and boosted as 
described above. Mice were bled every 2 wk to measure the antipeptide re-
sponse in serum. After 8 wk, mice were challenged with 100   μ  g MAP pep-
tide in IFA, and blood was drawn 5 d later to analyze the antipeptide 
antibody response. 
  Immunohistochemistry of kidneys.     To determine glomerular IgG de-
position, kidneys were obtained 13 wk after the initial immunization, fi  xed 
in 10% paraformaldehyde, and embedded in paraffi   n. Sections were blocked 
with 2% BSA and stained with biotinylated goat anti  –  mouse IgG. Alkaline 
phosphatase  –  labeled ABC reagent from the VECTASTAIN ABC kit (Vec-
tor Laboratories) was added. Sections were developed with 5-bromo-4-
chloro-3-indolyl phosphate-toluidine salt and nitroblue tetrazolium chloride 
substrate (Invitrogen). Proteinuria was determined by color comparison us-
ing Multistix (Sigma-Aldrich). 
  Purifi   cation of B cells.     For B cell purifi  cation, single-cell suspensions 
were prepared from splenocytes. After red blood cell lysis, cells were incu-
bated with biotinylated anti-CD3, anti-CD11b, and anti-CD11c mAb (BD 
Biosciences), and B cells were isolated by negative selection with magnetic 
streptavidin-linked Dynabeads (Invitrogen). After depletion,   >  90% of the 
remaining cells were B220  +   by fl  ow cytometry. All fl  ow cytometry was per-
formed on a FACSCalibur (Becton Dickinson) and analyzed with FlowJo 
Software (Tree Star, Inc.). 
  Purifi  cation of T cells.     Mice were immunized in the right front and hind 
footpads with 100   μ  g MAP peptide in 100   μ  l of 1:1 PBS/CFA and in the left 
front and hind footpads with 100   μ  l of 1:1 PBS/CFA alone (50   μ  l/footpad). 
1 wk later, left and right popliteal, axillary, and brachial lymph nodes were 
harvested, and a single cell suspension was prepared. Red blood cells were 
lysed, and cells at 2   ×   10  7   cells/ml were incubated at 4  °  C for 30 min with 
supernatants from the following ATCC cell lines: TIB-120 (anti-A  b,d,q   and 
anti-E  d,k  ), HB-198 (anti-F4/80), and anti-B220 (BD Biosciences). Excess 
antibody was washed away and the cells were incubated with sheep anti  –  rat 
IgG Dynal/Dynal beads at 4  °  C for 30 min. T cells were isolated by magnetic 
bead depletion (Invitrogen) and were demonstrated by fl  ow cytometry to be 
  >  95% pure. 
  Peritoneal macrophages.     To collect peritoneal macrophages, WT and 
Fc            /       mice were injected with 2 ml of 3% aged thioglycollate i.p. On day 
4, mice were killed and macrophages were harvested in Hank  ’  s balanced salt 
solution. The purity of the cell population was assessed by staining with F480 
antibody. All samples were   >  85% F480 positive. 
serum-free conditions also display an activated phenotype, 
which is, again, consistent with FcR engagement modulating 
DC function (  26  ). The activated phenotype was abrogated 
by addition of purifi  ed IgG to the culture. Although       chain  –
  containing Fc receptors have been demonstrated to be acti-
vating receptors, we speculated that engagement of these 
receptors may diminish the response to other activating re-
ceptors. Such reciprocal regulation of toll-like receptor 9 and 
IgE receptor signaling has already been demonstrated. Pro-
duction of type I IFN by plasmacytoid DC is inhibited by 
preexposure of Fc     RI to IgG (  33  ). These two signaling path-
ways counterregulate the development of Th1 and Th2 im-
mune response. Park-Min et al. (  34  ) recently demonstrated 
that immune complexes binding to Fc     RIII suppresses LPS-
mediated IFN      signaling in both human peripheral blood 
mononuclear cells derived macrophages and murine perito-
neal macrophages. A recent publication reported that human 
peripheral monocyte-derived DC cultures exposed to immune 
complexes show diminished diff  erentiation. Furthermore, in 
response to TLR-mediated stimulation, they produced less 
IL-12 (  35  ). This inhibition was mediated mainly through 
Fc     RI but, to a lesser extent by Fc     RII. Thus, there is prec-
edent for an absence of engagement of activating FcRs per-
mitting an enhanced response in other activation pathways. 
Although the mechanism for the altered function of Fc            /       
DC requires further confi  rmation, it is apparent that the dif-
ference in IL-12 production by DCs aff  ects B cell diff  erentia-
tion. This study reports the fi  rst in vivo manipulation that 
leads to diff  erential formation of short-lived and long-lived 
plasma cells. Understanding how to modulate B cell diff  eren-
tiation will facilitate an appreciation of the role of both short-
lived and long lived plasma cells. Furthermore, knowledge of 
the B cell phenotype responsible for the production of antiself 
or antimicrobial antibodies will help in the design of thera-
peutic strategies in autoimmune disease, as well as in optimiz-
ing vaccine development. 
  MATERIALS AND METHODS 
  Mice.     5  –  10-wk-old female Fc            /       mice (Fcer1g(BALB/cBy)) on the 
BALB/c background and WT BALB/c mice were purchased from Tacon-
ics. The mice were housed in a specifi  c pathogen-free barrier facility. IL-
12a       /       mice (C.129S1(B6)-  Il12a  tm1Jm    /J) were purchased from Jackson 
ImmunoResearch Laboratories. IL-12a       /       mice were bred to Fc            /       mice 
for the generation of mice that were IL-12 p35  +/       and Fc            /      . These studies 
were approved by the Institutional Animal Care and Use Committees of the 
Albert Einstein College of Medicine, Columbia University Medical Center, 
and Feinstein Institute for Medical Research. 
  Antigens.     The peptides DWEYSVWLSN, linked to an eight-branched 
poly-lysine backbone (MAP peptide), and ADGSGGRDEMQASMWS 
were purchased from both Invitrogen and AnaSpec, Inc. The peptide 
ADGSGGRDEMQASMWS (10  –  2) was conjugated to BSA with glutaral-
dehyde as previously described (  12  ). 
  Immunizations.     Mice were immunized i.p. with 100   μ  g MAP peptide or 
ADGSGGRDEMQASMWS-BSA in CFA (Becton Dickinson) on day 0 
and then boosted in IFA (Becton Dickinson) on days 7 and 14. For the recall 
assay, mice were immunized i.p. with 100   μ  g MAP peptide in CFA on day 
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ter LPS treatment, and cytokines were assayed in the culture supernatant 
using anti  –  mouse cytokine ELISA kits. Cytokine concentrations were deter-
mined based on standard curves. 
  For real-time PCR, total RNA was prepared from BMDCs either un-
stimulated or LPS-stimulated for 4 h using TRIzol Reagent (Invitrogen). 1   μ  g 
DNA-free RNA was reverse transcribed to cDNA using SuperScript III 
First-Strand Synthesis system for RT-PCR (Invitrogen). Real-time PCR 
was performed with TaqMan Universal PCR Master Mix (Applied Bio-
system) on an iCycler iQ instrument (Bio-Rad Laboratories). Amplifi  cation 
conditions were 50  °  C for 2 min and 95  °  C for 10 min, followed by 40 cycles 
of 95  °  C for 15 s and 60  °  C for 1 min. Primers for 18s ribosomal RNA, IL-
12a, IL-12b, and AID were purchased from Applied Biosystems. Relative 
expression was determined using the following formula: relative expression = 
2     –  (          CT)  , where           CT = [Ct (gene of interest sample) - Ct(18s rRNA sam-
ple)] - [Ct(gene of interest calibrator) - Ct(18s rRNA calibrator)]. (See the 
           CT methods, Taqman Bulletin 2; Applied Biosystems). Data are presented 
as the mean   ±   SD of three experiments. 
  In vivo cytokine production by splenic DCs.     BALB/c WT or Fc            /       
mice were immunized with 100   μ  g MAP peptide in CFA i.p. Each group of 
mice was killed on either day 1 or 3 after immunization. Splenic DCs were 
purifi  ed as described in Materials and methods and cultured in RPMI 1640 
supplemented with 10% FCS for 16 h. Supernatant was collected and cyto-
kine production was analyzed by ELISA. 
  BMDC and B cell coculture assays.     BMDCs were stained with anti-
CD11c PE (BD Biosciences) and sorted on a MoFlo Cell Sorter (Dako). 
More than 95% of the sorted cells were CD11c  +  . Mature BMDCs, irradiated 
with 1,500 rads, were cultured with 5   ×   10  4   B cells in triplicate in RPMI 
with 10% FCS in the presence of 20   μ  g/ml of purifi  ed anti-CD40 antibody 
(BD Biosciences). In some assays, 10   μ  g/ml of purifi  ed anti  –  IL-12 antibody 
(BD Biosciences) was added to the culture. 5 d later, 1   μ  Ci of   3  H-thymidine 
was added to each well for 8 h, and the incorporated radioactivity was deter-
mined. To block the secretion of IL-12 during the coculture, siRNA 
(siRNA ID#: 102773l; Ambion) targeting the IL-12a gene was transfected 
to BMDC according to the manufacturer  ’  s protocol. In brief, irradiated BM-
DCs cultured from both WT and Fc            /       mice were transfected with 1 and 
10   μ  M of anti  –  IL-12a specifi  c or negative control siRNA by siPORT 
NeoFX (Ambion). The next day, siRNA/transfection agents were removed 
and 5   ×   10  4   splenic B cells were added to the culture. 
  T cell proliferation.     T cells were purifi  ed from lymph nodes of MAP pep-
tide  –  primed WT or Fc            /       mice as described in Materials and methods. 
BMDCs were prepared from nonimmunized WT and Fc            /       mice and 
pulsed with MAP peptide on day 6 of culture. On day 7, 1  –  3   ×   10  5   primed 
T cells were cocultured in triplicate for 72 h with 5   ×   10  4   irradiated DCs. 
Cells were pulsed with 0.5   μ  Ci of   3  H-thymidine for the last 8 h. Cells were 
harvested, and the incorporated radioactivity was counted. 
  Analysis of V     usage and cytokine ELISAs.     Cells from the draining 
lymph nodes of naive mice or mice immunized 7 d earlier with MAP pep-
tide in CFA or CFA alone were harvested and plated at 3   ×   10  6   cells/ml in 
IMDM supplemented with 10% FCS, 2 mM glutamine, 100 U/ml penicil-
lin, 100   μ  g/ml streptomycin, and 50   μ  M      -mercaptoethanol in the presence 
of 50   μ  g/ml MAP peptide. 7 d later, the cultures were supplemented with 
50 U/ml of recombinant human IL-2 (Invitrogen) and 3   ×   10  6   RBC-de-
pleted irradiated (1,500 rads) splenocytes/ml along with fresh medium. 14 d 
after the initial culture, cells were collected. 2   ×   10  5   cells were stained with 
100   μ  l of 1   μ  g/ml CD4-PE in 2% FCS/PBS for 30 min on ice and then 
stained for the various V      chains using FITC-labeled antibodies. All labeled 
antibodies were obtained from BD Biosciences and data were acquired using 
a FACScan (Becton Dickinson). Peptide-specifi  c T cells were identifi  ed by 
comparison of lymph node cultures from mice immunized with MAP pep-
tide in CFA to those from mice immunized with CFA alone. Little prolifera-
tion was detected in the latter with 3  –  4 times as many live cells found in the 
peptide-specifi  c cultures compared with the CFA controls. 
  Purifi  cation of DCs.     BMDCs were generated according to a previously 
described protocol (  36  ). In brief, BM was harvested and red blood cells were 
lysed. T cells and B cells were depleted by incubating the cells with the 
ATCC supernatants TIB-120, TIB-211 (anti-CD8), TIB 207 (anti-CD4), 
and TIB-146 (anti-B220) in the presence of rabbit complement (Pel-Freez 
Biologicals). The remaining cells were cultured in RPMI 1640 with 5% FCS 
and GM-CSF-containing supernatant from J558L cells (gift of the laboratory 
of R. Steinman, The Rockefeller University, New York, NY). Cells were given 
fresh medium on days 2 and 4. On day 6, the nonadherent cells were col-
lected and were incubated overnight in medium with or without 50 ng/ml 
LPS from   Escherichia coli   serotype 055:B5 (Sigma-Aldrich). To further de-
plete monocytes, the cells were plated for 2 h, and nonadherent cells were 
collected. The depleted cells were   >  85% CD11c  +   by fl  ow cytometry. 
  To purify splenic DCs, a modifi  cation of the original method of Steinman 
et al. (  37  ) was used. In brief, spleen cell suspensions were prepared by diges-
tion with 400 U/ml collagenase D at 37  °  C for 25 min, followed by 0.5 M 
EDTA. Total splenocytes were washed and resuspended in 30% BSA. Ice-
cold PBS was loaded on top of the mixture. DCs were collected from the 
interface after centrifugation at 2,200 rpm for 30 min. To increase the purity 
of DCs, we used negative selection methods with a mouse DC enrichment 
set (BD Biosciences). After two steps of purifi  cation, the purity was mea-
sured by fl  ow cytometry and     75  –  80% of cells were CD11c  +  . 
  Enumeration of plasma cells.     Antigen-specifi  c plasma cells were enu-
merated in the spleen and BM of femurs by performing peptide-specifi  c 
ELISPOT assays. For plasma cells in the spleen, MAP peptide  –  immunized 
mice were killed and splenocytes were harvested. Red blood cells were 
lysed, and the splenocytes were added to plates coated with 10   μ  g/ml MAP 
peptide and blocked with 10% FCS. The plates were centrifuged at 1,000 
rpm for 5 min and incubated overnight at 37  °  C. The next day, splenocytes 
were washed stringently and biotinylated goat anti  –  mouse IgG (Southern-
Biotech) was added for 2 h at 37  °  C. Washed plates were incubated with 
streptavidin-alkaline phosphatase (SouthernBiotech) for 2 h and developed 
with 5-bromo-4-chloro-3-indolyl phosphate   p  -toluidine salt (Sigma-Aldrich). 
Spots were counted manually using a dissecting microscope. To enumerate 
plasma cells in the BM, CD138  +   cells were identifi  ed by fl  ow cytometry, 
and CD138  +   cells from WT and Fc            /       mice were sorted on a FACSAria 
and plated for MAP peptide  –  specifi  c ELISPOT analysis. 
  Spleen histology.     Spleens were harvested on days 0, 4, 8, 12, and 16 after 
immunization and snap frozen in Tissue-Tek O.C.T. compound (Sakura Fi-
netek). Sections were incubated with anti  –  mouse B220-FITC and CD138-PE, 
or B220-PE and PNA-FITC, and were visualized using a fl  uorescent micro-
scope (AxioCam II; Carl Zeiss, Inc.). 
  AID expression in germinal center B cells.     Expression of AID gene was 
measured in purifi  ed germinal center B cells. WT and Fc            /       mice were 
immunized with 100   μ  g of MAP peptide in CFA on day 0. On day 10, mice 
were killed and splenic B cells were purifi  ed by depletion of non-B cells: 
splenocytes were incubated with biotinylated anti-CD43, anti-CD11c, and 
anti-CD90.2 (BD Biosciences) and bound cells were removed by streptavi-
din-conjugated magnetic beads. B220 and PNA double-positive cells were 
isolated on a FACSAria as germinal center B cells, and B220-positive and 
PNA-negative fractions were collected as control cells. AID expression was 
measured by real-time PCR using total RNA from each fraction. Gene-spe-
cifi  c primers for AID were purchased from TaqMan, and real-time PCR was 
performed as described in Materials and methods. 
  Analysis of DC phenotype and cytokine secretion.     For cytokine secre-
tion, intracellular fl  ow cytometry was performed. LPS-treated or untreated 
BMDCs were cultured at 5   ×   10  5  /ml with 10   μ  g/ml brefeldin A (Sigma-Al-
drich) for 5 h. The cells were then stained with anti-CD11c PE (BD Biosci-
ences) and fi  xed in 2% paraformaldehyde for 10 min before staining with 
anti  –  IL-12 APC or anti  –  IL-10 APC in 0.3% saponin for 30 min. For cyto-
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  Cytokine ELISAs were performed on purifi  ed lymph node T cells for 
the detection of IL-2 and IFN-     . After 72 h of culture, T cell supernatants 
were tested using the mouse cytokine ELISA kit (Endogen). Cytokine con-
centrations were determined based on a standard curve. 
  In vivo IL-12 treatment.     Mice were injected i.p. with 1   μ  g rIL-12 or saline 
on days      1, 0, and 1 after immunization with MAP peptide in CFA. Mice 
were then boosted as described in Materials and methods with no further ad-
ministration of IL-12. On day 25, mice were killed, and a peptide-specifi  c 
ELISPOT assay was performed on splenocytes. BM cells were harvested, and 
plasma cells were enumerated by fl  ow cytometry as described above. 
  Generation of hybridomas and sequencing J  H  2-J  H  4 region.     BALB/c 
WT and Fc            /       mice were immunized as described in Materials and methods. 
3 d after boosting, mice were killed and total splenocytes were harvested. Cells 
were fused with the NSO myeloma fusion partner using standard hybridoma 
technology. 2 wk after fusion, antipeptide antibody secreting clones were 
screened. Genomic DNA was purifi  ed from positive clones by TRIzol 
reagent. The J  H  2  –  J  H  4 region was amplifi  ed using Pfu turbo (Stratagene) fol-
lowed by previously described protocol (  38  ). PCR was performed with the 
following primers: 5      primer, 5     -GGCACCACTCTCACAGTCTCCT-
CAGG-3     ; and 3      primer, 5     -TGAGACCGAGGCTAGATGCC-3     . PCR 
conditions were the following: 95  °  C for 30 s, 60  °  C for 30 s, and 72  °  C for 
15 min for 35 cycles. PCR products were purifi  ed and sequenced at the DNA 
sequencing facility at the Columbia University Medical Center. 
  In vivo depletion of CD4+ T cells.     The GK1.5 monoclonal antibody 
(rat IgG2b anti  –  murine CD4) was used for in vivo depletion of CD4 T cells. 
500   μ  g of antibody was administered by i.p. injection of 0.1 ml of saline on 
days      1, 0, and 1 after immunization with MAP peptide in CFA. Blood 
samples were collected on day 0 and every 2 wk for 8 wk. 
  Statistics.     Comparisons between groups were performed by Student  ’  s   t   test. 
A two-way analysis of variance test was used to compare curves in ELISA as-
says. Error bars represent SD values, and p-values   <  0.05 were considered to 
be statistically signifi  cant. 
  Online supplemental material.     Fig. S1 shows serum anti  –  MAP peptide 
IgM titer. Fig. S2 shows the increased surface activation markers in BMDCs 
by FACS analysis. Fig. S3 shows the specifi  c inhibition of IL-12a expression 
after siRNA treatment in BMDCs. Fig. S4 shows the relative expression 
of IL-12a in splenic DCs from WT, Fc            /      , and Fc            /      .IL-12a  +/       mice. 
Fig. S5 shows titer of anti  –  MAP peptide and anti-dsDNA antibody in se-
rum from WT, Fc            /      , and FcRI       /       mice. Fig. S6 is for the expression 
of chemokine/chemokine receptor in splenic B cells and DCs. Table S1 
shows the number of germinal centers in MAP peptide  –  immunized WT 
and Fc            /      . Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20070731/DC1. 
  We want to thank Sylvia Jones for help in preparation of the manuscript. 
  This work was supported by a grant from the National Institutes of Health. S.J. 
Kim is a recipient of a SLE Foundation Fellowship. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   10 April 2007 
Accepted:   29 August 2008 
  REFERENCES 
       1  .   Putterman  ,   C.  , and   B.     Diamond  .   1998  .   Immunization with a peptide sur-
rogate for double-stranded DNA (dsDNA) induces autoantibody produc-
tion and renal immunoglobulin deposition.       J. Exp. Med.       188  :  29    –    38  .    
       2  .   Khalil  ,   M.  ,   K.     Inaba  ,   R.     Steinman  ,   J.     Ravetch  , and   B.     Diamond  .   2001  . 
  T cell studies in a peptide-induced model of systemic lupus erythemato-
sus.       J. Immunol.       166  :  1667    –    1674  .   
       3  .   Takai  ,   T.  ,   M.     Li  ,   D.     Sylvestre  ,   R.     Clynes  , and   J.V.     Ravetch  .   1994  .   FcR 
gamma chain deletion results in pleiotrophic eff  ector cell defects.       Cell      .   
  76  :  519    –    529  .    2448 DENDRITIC CELLS INFLUENCE B CELL FATE   | Kim et al. 
        27  .   Metzger  ,   D.W.  ,   R.M.     McNutt  ,   J.T.     Collins  ,   J.M.     Buchanan  ,   V.H.     Van 
Cleave  , and   W.A.     Dunnick  .   1997  .   Interleukin-12 acts as an adjuvant for 
humoral immunity through interferon-gamma-dependent and -inde-
pendent mechanisms.       Eur. J. Immunol.       27  :  1958    –    1965  .    
        28  .   Durali  ,   D.  ,   M.G.     de Goer de Herve  ,   J.     Giron-Michel  ,   B.     Azzarone  , 
  J.F.     Delfraissy  , and   Y.     Taoufi  k  .   2003  .   In human B cells, IL-12 trig-
gers a cascade of molecular events similar to Th1 commitment.       Blood      .   
  102  :  4084    –    4089  .    
        29  .   Gatto  ,   D.  ,   T.     Pfi  ster  ,   A.     Jegerlehner  ,   S.W.     Martin  ,   M.     Kopf  , and   M.F.   
  Bachmann  .   2005  .   Complement receptors regulate diff  erentiation  of 
bone marrow plasma cell precursors expressing transcription factors 
Blimp-1 and XBP-1.       J. Exp. Med.       201  :  993    –    1005  .    
        30  .   Grimaldi  ,   C.M.  ,   J.     Cleary  ,   A.S.     Dagtas  ,   D.     Moussai  , and   B.     Diamond  . 
  2002  .   Estrogen alters thresholds for B cell apoptosis and activation.   
    J. Clin. Invest.       109  :  1625    –    1633  .   
        31  .   McGaha  ,   T.L.  ,   B.     Sorrentino  , and   J.V.     Ravetch  .   2005  .   Restoration of 
tolerance in lupus by targeted inhibitory receptor expression.       Science.     
  307  :  590    –    593  .    
        32  .   Nimmerjahn  ,   F.  , and   J.V.     Ravetch  .   2005  .   Divergent immunoglobu-
lin g subclass activity through selective Fc receptor binding.       Science.     
  310  :  1510    –    1512  .    
        33  .   Schroeder  ,   J.T.  ,   A.P.     Bieneman  ,   H.     Xiao  ,   K.L.     Chichester  ,   K.     Vasagar  , 
  S.     Saini  , and   M.C.     Liu  .   2005  .   TLR9- and FcepsilonRI-mediated responses 
oppose one another in plasmacytoid dendritic cells by down-regulating 
receptor expression.       J. Immunol.       175  :  5724    –    5731  .   
        34  .   Park-Min  ,   K.H.  ,   N.V.     Serbina  ,   W.     Yang  ,   X.     Ma  ,   G.     Krystal  ,   B.G.   
  Neel  ,   S.L.     Nutt  ,   X.     Hu  , and   L.B.     Ivashkiv  .   2007  .   FcgammaRIII-de-
pendent inhibition of interferon-gamma responses mediates suppressive 
eff  ects of intravenous immune globulin.       Immunity      .     26  :  67    –    78  .    
        35  .   Laborde  ,   E.A.  ,   S.     Vanzulli  ,   M.     Beigier-Bompadre  ,   M.A.     Isturiz  ,   R.A.   
  Ruggiero  ,   M.G.     Fourcade  ,   A.C.     Catalan Pellet  ,   S.     Sozzani  , and   M.   
  Vulcano  .   2007  .   Immune complexes inhibit diff  erentiation, maturation, 
and function of human monocyte-derived dendritic cells.       J. Immunol.     
  179  :  673    –    681  .
      36  .   Inaba  ,   K.  ,   M.     Inaba  ,   N.     Romani  ,   H.     Aya  ,   M.     Deguchi  ,   S.     Ikehara  ,   S.   
  Muramatsu  , and  R.M.    Steinman  .  1992  .  Generation of large numbers of den-
dritic cells from mouse bone marrow cultures supplemented with granulo-
cyte/macrophage colony-stimulating factor.       J. Exp. Med.       176  :  1693    –    1702  .   
        37  .   Steinman  ,   R.M.  ,   G.     Kaplan  ,   M.D.     Witmer  , and   Z.A.     Cohn  .   1979  . 
  Identifi  cation of a novel cell type in peripheral lymphoid organs of mice. 
V. Purifi  cation of spleen dendritic cells, new surface markers, and main-
tenance in vitro.       J. Exp. Med.       149  :  1    –    16  .    
        38  .   Bardwell  ,   P.D.  ,   A.     Martin  ,   E.     Wong  ,   Z.     Li  ,   W.     Edelmann  , and   M.D.   
  Scharff    .   2003  .   Cutting edge: the G-U mismatch glycosylase methyl-
CpG binding domain 4 is dispensable for somatic hypermutation and 
class switch recombination.       J. Immunol.       170  :  1620    –    1624  .                           